907208-89-3

Basic information

• Product Name: 4-(5-Methyl-pyridin-2-yl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H23N3O2, MW: 277.36
• Synonyms: 4-(5-Methyl-pyridin-2-yl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H23N3O2, MW: 277.36;1-(tert-Butoxycarbonyl)-4-(5-methylpyridin-2-yl)piperazine;tert-butyl 4-(5-methylpyridin-2-yl)piperazine-1-carboxylate
• CAS NO: 907208-89-3
• Molecular Formula: C₁₅H₂₃N₃O₂
• Molecular Weight: 277.36202
• Mol File: 907208-89-3.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Density: 1.111
• CAS DataBase Reference: 4-(5-Methyl-pyridin-2-yl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H23N3O2, MW: 277.36(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-Methyl-pyridin-2-yl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H23N3O2, MW: 277.36(907208-89-3)
• EPA Substance Registry System: 4-(5-Methyl-pyridin-2-yl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H23N3O2, MW: 277.36(907208-89-3)

Safety Data

• Hazardous Substances Data: 907208-89-3(Hazardous Substances Data)

Usage

General Description

The chemical 4-(5-Methyl-pyridin-2-yl)-piperazine-1-carboxylic acid tert-butyl ester, 98+% C15H23N3O2, MW: 277.36 is a compound with a molecular formula of C15H23N3O2 and a molecular weight of 277.36. It is a piperazine derivative with a tert-butyl ester functional group attached to the carboxylic acid. This chemical has a purity of 98% or higher, indicating that it is a high-quality compound suitable for various research and industrial applications. Its structure and properties make it a potentially important building block in the synthesis of pharmaceuticals, agrochemicals, or other organic compounds.

Upstream product

• 3510-66-5 2-Bromo-5-methylpyridine 
• 57260-71-6 1-t-Butoxycarbonylpiperazine 
• 72093-07-3 2-methyl-5-chloropyridine 
• 18368-64-4 2-chloro-5-methylpyridine 

Downstream Products

• 104395-86-0 1-(5-methyl-pyridin-2-yl)piperazine 

Relevant articles and documents

Remarkably Efficient Iridium Catalysts for Directed C(sp2)-H and C(sp3)-H Borylation of Diverse Classes of Substrates

Here we describe the discovery of a new class of C-H borylation catalysts and their use for regioselective C-H borylation of aromatic, heteroaromatic, and aliphatic systems. The new catalysts have Ir-C(thienyl) or Ir-C(furyl) anionic ligands instead of the diamine-type neutral chelating ligands used in the standard C-H borylation conditions. It is reported that the employment of these newly discovered catalysts show excellent reactivity and ortho-selectivity for diverse classes of aromatic substrates with high isolated yields. Moreover, the catalysts proved to be efficient for a wide number of aliphatic substrates for selective C(sp3)-H bond borylations. Heterocyclic molecules are selectively borylated using the inherently elevated reactivity of the C-H bonds. A number of late-stage C-H functionalization have been described using the same catalysts. Furthermore, we show that one of the catalysts could be used even in open air for the C(sp2)-H and C(sp3)-H borylations enabling the method more general. Preliminary mechanistic studies suggest that the active catalytic intermediate is the Ir(bis)boryl complex, and the attached ligand acts as bidentate ligand. Collectively, this study underlines the discovery of new class of C-H borylation catalysts that should find wide application in the context of C-H functionalization chemistry.

A class of GPR40 agonist compounds with amide structure, and uses thereof

The present invention relates to a class of amide compounds with a novel structure, and a pharmaceutical composition thereof, wherein the structure of the amide compound is represented by a general formula (I). According to the present invention, the amide compound (I) can regulate GPR40 activity, and can be used for GPR40 activity related diseases such as diabetes and metabolic syndrome. The formula I is defined in the specification.

SULFONIC ACID SALTS OF HETEROCYCLYLAMIDE-SUBSTITUTED IMIDAZOLES

The invention relates to sulfonic acid salts of heterocyclylamide-substituted imidazoles, and to solvates and hydrates thereof, to the use thereof for treating and/or preventing diseases, and to use thereof for producing drugs for treating and/or preventi